case_id,genetic_tests,realistic_all_3,text,run1_realistic,run2_realistic,run3_realistic
Case2150,WES,False,"NO
This case is unrealistic because a neonatologist should not be managing or ordering genetic testing for a 17-year-old adolescent.",False,False,False
Case2476,WES,True,"The patient is a 6-year-old referred for whole exome sequencing to evaluate multiple congenital anomalies, and Fragile X testing was performed previously and was non-diagnostic; an oncologist is the ordering provider and no genetic counseling has been conducted prior to testing. Family history is notable for a sibling who experienced a brief resolved unexplained event characterized by altered level of responsiveness with cyanosis, pallor, and irregular breathing. The patient’s insurance is BCBS_FEP.",True,True,True
Case3255,WES,False,"NO
The case is prenatal and therefore cannot include neurodevelopmental terms such as autism spectrum disorder as an indication for testing.",False,False,False
Case811,WES,True,"The patient is a 7-week-old infant presenting with early-onset movement abnormalities described as dystonia, ataxia and hemiplegia concerning for a neuromuscular or other neurologic disorder, and clinical exome sequencing (WES) is being ordered after a non-diagnostic chromosomal microarray (CMA); the test was ordered by the general pediatrician, the family reports a sibling with multiple congenital anomalies, the family carries BCBS_FEP insurance, and a genetic counselor saw the family before testing and will follow up after results are returned.",True,True,True
Case3880,WES,False,"NO
Meconium ileus is a neonatal condition and cannot plausibly be the clinical indication for a 70-year-old patient.",False,False,False
Case2496,WES,True,"A fetus at 32 weeks' gestation is being evaluated because of parental consanguinity, with a family history notable for a brother who died suddenly and unexpectedly before age 35; FISH testing was previously performed and was non-diagnostic. A neonatologist has ordered whole exome sequencing (WES) to investigate potential recessive conditions given the consanguinity, no genetic counseling has been conducted to date, and the family is insured through UHC.",True,True,True
Case4262,WES,True,"The 5-week-old infant is being evaluated for multiple congenital anomalies that do not fit a well-delineated genetic syndrome, and whole exome sequencing (WES) has been ordered by the oncologist after prior karyotype testing was non-diagnostic; there is a sibling history of a brief resolved unexplained event characterized by altered level of responsiveness with cyanosis, pallor and irregular breathing, the family’s insurance is BCBS_FEP, and the patient saw a genetic counselor for pre-test counseling and will return to the counselor for review of results.",True,True,True
Case1892,WES,False,"The patient is a 13-year-old being evaluated for a history of meconium ileus dating to the neonatal period, and whole exome sequencing (WES) is being ordered by a Medical Geneticist after prior FISH testing was non-diagnostic; the family reports parental consanguinity, the patient is insured through BCBS_FEP, and a genetic counselor has seen the patient before testing and will provide follow-up after results are received.",True,False,True
Case4458,WES,False,"NO
A neonate at 0 weeks cannot be currently diagnosed with autism or a complex neurodevelopmental disorder because these conditions are not diagnosable at birth.",False,False,False
Case1519,WES,False,"The 13-year-old presents for evaluation of recurrent witnessed seizure‑like events and an episode described as a high‑risk brief resolved unexplained event, and whole exome sequencing has been ordered by the gynecologist to investigate a possible genetic cause; prior chromosomal microarray was performed and was non‑diagnostic. The family history is notable for a maternal uncle with a persistent, severe hematologic disorder. The patient saw a genetic counselor before testing and will return to the genetic counselor for post‑test counseling, and insurance coverage is BCBS_FEP.",False,True,False
Case4970,WES,True,"The patient is a 10-year-old child with BCBS_FEP insurance being evaluated for an ocular coloboma, and whole exome sequencing is being pursued to look for an underlying genetic syndrome; Fragile X testing was performed previously and was non-diagnostic. The family history is notable for multiple relatives with breast cancer, including the patient’s mother and a maternal aunt. The test was ordered by a Family Medicine Physician and no genetic counseling has been conducted to date.",True,True,True
Case4735,WES,False,"NO
A 6-year-old child being managed by a neonatologist is unrealistic because neonatologists care for newborns and not pediatric patients of that age.",False,False,False
Case4585,WES,False,"NO
A 6-week-old infant cannot plausibly have lobular breast cancer, and the scenario improperly mixes adult-onset hereditary cancer indications with a pediatric neurodevelopmental regression context.",False,False,False
Case3828,WES,False,"NO
Prenatal cases cannot be described with neurodevelopmental diagnoses such as intellectual disability, so a fetus at 25 weeks gestation with that indication is not realistic.",False,False,False
Case2847,WES,True,"The 5-week-old infant is being evaluated for a high-risk Brief Resolved Unexplained Event that required cardiopulmonary resuscitation, and a cardiologist has ordered whole exome sequencing (WES) with coverage through BCBS_FEP; prior chromosomal microarray (CMA) testing was nondiagnostic. The mother has a history of a persistent, severe immunologic or hematologic disorder, and a genetic counselor saw the family before testing and will provide follow-up counseling after results are available.",True,True,True
Case3959,WES,True,"The patient is a 2-week-old infant being evaluated for congenital choanal atresia, and whole exome sequencing (WES) has been ordered by the primary care physician to investigate a potential underlying genetic cause; Fragile X testing was previously performed and was non-diagnostic. The mother has a history of a persistent severe immunologic or hematologic disorder. A genetic counselor saw the family before testing and will provide follow-up counseling after results are available, and insurance is BCBS_FEP.",True,True,True
Case2597,WES,True,"At 17 weeks' gestation the fetus is being evaluated for a prenatally identified soft tissue sarcoma on ultrasound, and the pregnancy is being assessed for an underlying genetic etiology given that the mother has a history of multiple congenital anomalies; karyotype testing was performed and was non-diagnostic. The General Practitioner has ordered whole exome sequencing (WES) with UHC coverage. The mother has seen a genetic counselor multiple times and will follow up with the counselor for pre-test discussion and post-test counseling.",True,True,True
Case3385,WES,True,"An infant aged 0 years is being evaluated for a congenital ocular coloboma, and the case was referred by the developmental pediatrician with whole exome sequencing planned under UHC coverage; Fragile X testing was previously performed and was non-diagnostic. The family history is notable for an older sibling with autism spectrum disorder. The family has seen a genetic counselor multiple times and will continue genetics follow-up in conjunction with the planned WES.",True,True,True
Case4296,WES,True,"The newborn (0 weeks) presented with meconium ileus and a medical geneticist has ordered whole exome sequencing to evaluate an underlying genetic cause; prior karyotype testing was non-diagnostic, the family history is notable for a sibling who was diagnosed with severe intellectual disability in childhood, and insurance coverage is through UHC.",True,True,True
Case4177,WES,True,"A 19-week gestation fetus is being evaluated for a major congenital cardiac anomaly, and whole exome sequencing (WES) has been ordered after prior karyotype testing was non-diagnostic; there is a family history in a sibling who experienced a Brief Resolved Unexplained Event characterized by altered level of responsiveness, cyanosis, pallor, and irregular breathing, the order was placed by a nurse practitioner, no genetic counseling has been conducted to date, and insurance coverage is through Cigna.",True,True,True
Case129,WGS,True,"The patient is 12 years old and is being evaluated by a neurologist for a complex neurodevelopmental disorder with autism spectrum features; the clinician has ordered whole genome sequencing (WGS) for diagnostic clarification after prior chromosomal microarray (CMA) testing was non-diagnostic, there is a reported family history of long QT syndrome in the patient's mother, and testing will be billed to UHC.",True,True,True
Case2324,WGS,True,"The 12-year-old patient is being evaluated for Hirschsprung disease and whole genome sequencing (WGS) has been ordered to investigate a possible genetic cause; there has been no prior genetic testing. The order was placed by a gynecologist, the family discussed testing with a genetic specialist, and the family history is notable for the patient's mother having had triple-negative breast cancer. Testing will be submitted to UHC.",True,True,True
Case3032,WGS,True,"The patient is a 6-week-old infant being evaluated by a neurologist for dystonia, ataxia, hemiplegia and other movement and neuromuscular abnormalities; whole genome sequencing (WGS) is planned under UHC after prior FISH testing was non-diagnostic, there is a history of an older sibling with global developmental delay, and the family declined genetic counseling.",True,True,True
Case280,WGS,True,"The patient is an 8-year-old child being evaluated for multiple congenital anomalies, and the General Pediatrician has ordered whole genome sequencing (WGS) through BCBS_FEP after prior karyotype testing was non-diagnostic; the family reports parental consanguinity and a sibling in the family, and they saw a genetic counselor prior to testing with plans to follow up after results are received.",True,True,True
Case499,WGS,True,"At 1 year of age, the patient is being evaluated for abnormal muscle tone characterized by hypotonia in infancy; the neonatologist has ordered whole genome sequencing (WGS) through UHC after chromosomal microarray (CMA) was non‑diagnostic, no genetic counseling has been conducted to date, and there is a maternal history of a growth abnormality.",True,True,True
Case3623,WGS,False,"NO
The scenario is unrealistic because a 50-year-old adult is being managed by a general pediatrician, violating the rule that adults cannot be managed by pediatric providers.",False,False,False
Case881,WGS,True,"The patient is a 2-week-old infant being evaluated for concern about intellectual disability, with a family history notable for an older sibling who experienced unexplained developmental regression not attributable to autism or epilepsy; a cardiologist has ordered whole genome sequencing (WGS) after prior FISH testing was non-diagnostic, the family saw a genetic counselor before testing and will follow up with the counselor after results are returned, and insurance is BCBS_FEP.",True,True,True
Case4346,WGS,True,"The 9-year-old patient was evaluated by a Neurologist for global developmental delay and has a sibling with autism spectrum disorder; prior Fragile X testing was non-diagnostic. The Neurologist has ordered whole genome sequencing (WGS) to investigate an underlying genetic etiology, the patient carries UHC insurance, and the patient has seen a genetic counselor multiple times with planned continued genetic counseling for pre-test education and post-test follow-up.",True,True,True
Case3296,WGS,True,"The 10-year-old patient is being evaluated for autism spectrum disorder and was referred by a neurologist for whole genome sequencing (WGS) after a chromosomal microarray (CMA) was non-diagnostic; the family reports a sibling who had hypotonia in infancy. The child has seen a genetic counselor multiple times and will continue genetic counseling for result interpretation, and testing will be billed to UHC.",True,True,True
Case2674,WGS,True,"The patient is a 17-year-old evaluated by a neurologist for dystonia, ataxia, hemiplegia and other movement abnormalities; the patient's mother has a history of a similar movement disorder. A chromosomal microarray (CMA) was previously performed and was non-diagnostic, and the neurologist has ordered whole genome sequencing (WGS) to investigate an underlying genetic etiology; no genetic counseling has been conducted to date. Insurance coverage is through UHC.",True,True,True
Case2007,BRCA1/2,True,"The 18-year-old patient with metastatic breast cancer is undergoing germline BRCA1/2 testing ordered by a Family Medicine Physician; chromosomal microarray (CMA) was previously performed and was non-diagnostic. The patient saw a genetic counselor prior to testing and will return for post-test counseling, and she reports a mother who was diagnosed with breast cancer at age 50 or younger. Insurance for testing is BCBS_FEP.",True,True,True
Case1695,BRCA1/2,False,"NO
This is a prenatal case (27 weeks' gestation) but includes a neurodevelopmental indication (""global developmental delay""), and prenatal cases must not list neurodevelopmental or developmental delay outcomes for fetal testing.",False,False,False
Case1708,BRCA1/2,False,"NO
This is unrealistic because ordering BRCA1/2 adult hereditary cancer testing for a 14-year-old being evaluated for significant hypotonia represents a contextual inconsistency between a pediatric neurologic indication and adult-onset cancer susceptibility testing.",False,False,False
Case1728,BRCA1/2,False,"NO
Testing a 31-week gestation fetus for adult-onset cancer susceptibility (BRCA1/2) is not appropriate because prenatal genetic testing is limited to karyotype, chromosomal microarray, or exome/genome sequencing and does not include single-gene BRCA testing for adult-onset cancer.",False,False,False
Case1817,BRCA1/2,False,"NO
BRCA1/2 testing is inappropriate for a fetus at 38 weeks gestation because prenatal testing is limited to karyotype, CMA, or prenatal WES/WGS and adult-onset cancer susceptibility single-gene testing on a fetus is not realistic.",False,False,False
Case1367,BRCA1/2,True,"The 62-year-old patient has a history of breast cancer diagnosed at or before age 50 and is undergoing BRCA1/2 testing ordered by the primary care physician; chromosomal microarray (CMA) was previously performed and was non-diagnostic. The patient reports a brother with pancreatic cancer, carries BCBS_FEP insurance, and saw a genetic counselor before testing with plans to follow up with the counselor after the results are received.",True,True,True
Case3175,BRCA1/2,True,"A 33-year-old woman with UHC insurance is undergoing BRCA1/2 testing for assessment of hereditary breast and prostate cancer risk because she reports a mother with breast cancer and a maternal uncle with prostate cancer on the same side of the family; she has had no prior genetic testing, the test was ordered by her gynecologist, and she has seen a genetic counselor multiple times.",True,True,True
Case3975,BRCA1/2,True,"A 34-year-old patient is being evaluated for a high-risk brief resolved unexplained event (BRUE) with a significantly abnormal electrocardiogram concerning for channelopathy, arrhythmia, cardiomyopathy, myocarditis, or other structural heart disease; chromosomal microarray (CMA) was previously performed and was non-diagnostic. The patient has a family history notable for a father with arrhythmia, the Primary Care Physician placed an order for BRCA1/2 testing, the patient is insured by BCBS_FEP, and the patient declined genetic counseling.",True,True,True
Case22,BRCA1/2,True,"An 18-year-old man is undergoing BRCA1/2 testing for hereditary prostate cancer risk given the indication of prostate cancer with metastatic disease, intraductal/cribriform histology, or classification as high- to very-high-risk; he reports a father with metastatic prostate cancer with intraductal/cribriform histology. Chromosomal microarray (CMA) was previously performed and was non-diagnostic. The test was ordered by a neurologist; he saw a genetic counselor prior to testing and will follow up with the counselor after results are returned, and his insurance is BCBS_FEP.",True,True,True
Case3705,BRCA1/2,False,"NO
BRCA1/2 testing is inconsistent with a 7-year-old's evaluation for global developmental delay, since adult hereditary cancer gene testing should not be used to investigate pediatric neurodevelopmental disorders.",False,False,False
Case2546,BRCA1/2,True,"The patient is a 16-year-old presenting for evaluation of a major congenital abnormality affecting at least one organ system and has a family history of breast cancer in her mother diagnosed at age 50 years or younger; prior chromosomal microarray analysis (CMA) was non-diagnostic. The obstetrician has ordered BRCA1/2 testing, the patient has seen a genetic counselor multiple times for pre-test counseling and will follow up after results, and the evaluation is covered by Cigna.",True,True,True
Case3589,BRCA1/2,False,"NO
The indication ""multiple congenital anomalies"" is a pediatric-only label and is not a valid current clinical indication for a 72-year-old adult.",False,False,False
Case3985,BRCA1/2,True,"The 53-year-old woman with triple-negative breast cancer is undergoing BRCA1/2 testing and previously had karyotype testing which was non-diagnostic; she reports a family history notable for her father having high-risk metastatic prostate cancer, the test was ordered by a medical geneticist, she saw a genetic counselor before testing and will follow up with the counselor after results are received, and her testing will be billed to Cigna.",True,True,True
Case4923,BRCA1/2,False,"NO
The case presents adult-onset hereditary cancer testing (BRCA1/2) in the same evaluation as a family history of unexplained developmental regression, creating a contextual inconsistency that makes the scenario unrealistic.",False,False,False
Case126,BRCA1/2,False,"NO
Prenatal cases cannot list neurodevelopmental indications such as global developmental delay, and BRCA1/2 testing is inappropriate for a fetus.",False,False,False
Case2552,CMA_developmental_disorder,True,"The patient is a 58-year-old adult with a personal history of exocrine pancreatic cancer who is undergoing genetic evaluation; the General Practitioner has ordered a chromosomal microarray (CMA) targeted for developmental disorders. The patient reports a brother with autism spectrum disorder, previously underwent FISH testing which was non-diagnostic, has seen a genetic counselor multiple times, and insurance coverage is BCBS_FEP.",True,True,True
Case10,CMA,True,"The patient is a 1-year-old referred for evaluation of an abnormality affecting at least one organ system with concerns for a complex neurodevelopmental disorder, and there is a family history of an older sibling with global developmental delay; Fragile X testing was previously performed and was non-diagnostic. The Developmental Pediatrician has ordered chromosomal microarray analysis (CMA) to assess for copy-number variants, the patient is covered by Cigna insurance, and the family declined pre-test genetic counseling.",True,True,True
Case1298,CMA_tumor,False,"NO
The case is unrealistic because it describes a 19-week fetus with a personal history of an adult primary solid tumor and BRCA risk assessment, which a prenatal patient cannot have.",False,False,False
Case4725,CMA_developmental_disorder,True,"A 12-year-old is being evaluated for a major abnormality involving at least one organ system, and the general practitioner has ordered chromosomal microarray (CMA) for developmental disorders to investigate the etiology; Fragile X testing was previously performed and was non-diagnostic, and the family history is notable for a sibling with epileptic encephalopathy with onset before three years of age, with coverage through Cigna.",True,True,True
Case2578,CMA_developmental_disorder,True,"At 13 weeks' gestation, the pregnancy is being evaluated for suspected meconium ileus and chromosomal microarray analysis (CMA) has been ordered; the patient is insured by UHC. Prior FISH testing was non-diagnostic. The test was ordered by a General Practitioner, the patient declined pre-test genetic counseling, and family history is notable for a previous child affected by an inborn error of metabolism.",True,True,True

Summary,,,,,,
Total cases,50,,,,,
All 3 sets realistic,31,,,,,
All 3 sets realistic percentage,62.0%,,,,,
